This new book summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone and venlafaxine in treating patients with MDD, dysthymia and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia or neurovegetative symptoms..
Compre este e-book e ganhe mais 1 GRÁTIS!
Formato PDF ● Páginas 475 ● ISBN 9781536115543 ● Editor Diane C Wimmer ● Editora Nova Science Publishers ● Publicado 2017 ● Carregável 3 vezes ● Moeda EUR ● ID 7216850 ● Proteção contra cópia Adobe DRM
Requer um leitor de ebook capaz de DRM